Inactive Instrument
Stemcell Holdings, Inc. Share Price Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 16.43L | |
| -0.58% | +0.43% | +31.09% | -4.81% | 7.84TCr | |
| -2.55% | +6.99% | +505.27% | +47.92% | 6.15TCr | |
| -1.11% | +5.08% | -11.47% | -33.91% | 5.98TCr | |
| +0.14% | -1.20% | -11.64% | +24.21% | 4.65TCr | |
| -0.24% | +1.22% | +2.26% | +151.03% | 4.55TCr | |
| -1.62% | -0.76% | +49.85% | -14.92% | 3.18TCr | |
| -1.81% | +3.16% | +45.71% | +110.57% | 2.54TCr | |
| +0.47% | +3.26% | -0.77% | +142.41% | 2.14TCr | |
| +0.27% | +1.96% | +62.19% | +102.81% | 1.58TCr | |
| Average | -0.70% | +2.20% | +74.72% | +58.37% | 4.29TCr | |
| Weighted average by Cap. | -0.92% | +2.35% | +93.51% | +40.27% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 33.39L 29.11L 27.49L 24.96L 46.77L 32Cr 46.97L 3.29Cr 1.27Cr 16Cr 1.25Cr 1.23Cr 52Cr | 61.8L 53.89L 50.88L 46.21L 86.57L 59Cr 86.93L 6.1Cr 2.35Cr 30Cr 2.32Cr 2.27Cr 97Cr |
| Net income | 14.02L 12.23L 11.55L 10.49L 19.65L 13Cr 19.73L 1.38Cr 53.38L 6.84Cr 52.68L 51.51L 22Cr | 24.1L 21.01L 19.84L 18.02L 33.76L 23Cr 33.9L 2.38Cr 91.71L 12Cr 90.52L 88.51L 38Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
